Kevin Kawchak's Contact Details

Kevin Kawchak's Company Details

ChemicalQDevice

San Diego, CA, US • Not Available Employees
BioTech/Drugs

Mission Statement: To improve Quantum Machine Learning Neuroimaging (QMLN) techniques utilizing quantum technologies for better sensitivity, signal strength, and/or resolution leading to enhanced images and advanced prediction in neuroradiology for Alzheimer's disease.North Star Metric: The number of doctor approvals ordering revised CT, MRI, and/or MEG tests. Neuroradiologists are important because they play a vital role in ensuring optimal patient care.Vision: Quantum based sensing, algorithms, and/or computing platforms implemented for advanced precision medicine.BHAG: Contentment of hospital administrators with image quality improvements in United States hospital systems. Product Positioning Statement: For: Hospital critical care unitsWho: Doctors pained with insufficient image qualityThe: Quantum based technologies used to gain performanceThat: Have specific advantages in sensing, instruction, and/or computingUnlike: Current methods due to faster analyses that offer potential for better predictionHow will ChemicalQDevice be Better than their Competitors?The quantum information science field is a bleeding edge technology with the capabilities to provide more sensing and processing benefits versus existing "digital" solutions. Quantum enabled imaging services will be able to take advantage of quantum mechanical effects of superpositioning and entanglement that will enable better brain images. ChemicalQDevice will leverage quantum advantages by enabling precision and accuracy beyond what is available with current offerings.Value Proposition: ChemicalQDevice is for hospitals desiring to save time and money over time in the form of empty hospital beds. The improved services are for doctors pained with insufficient imaging capabilities that contribute to higher rates of Sudden Unexpected Deaths.Startup Status: Actively seeking funding, pre-revenue.